Patent · US Active

Tumor-specific recognition molecules

US8617846B2 · kind B2 · utility

4Cited by

6References

22Claims

0Family size

Assignee

Glycotope GmbH · DE

Inventors

Steffen Goletz · Berlin, DE
Antje Danielczyk · Kolberg, DE
Uwe Karsten · Berlin, DE
Peter Ravn · Hadsten, DK
Renate Stahn · Berlin, DE
Peter Astrup Christensen · Vejen, DK

Key dates

Filing date	Nov 22, 2011
Grant date	Dec 31, 2013
Priority date	—
Expiry date	Nov 22, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to recognition molecules which are directed towards tumors and can be used in the diagnosis and therapy of tumor diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.